Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tubeless Strategy Within an ERAS Protocol for Thoracoscopic Sublobar Resection
NCT07409129Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in pulmonary nodules (SPN) and lung cancer (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: 24-hour high-quality recovery rate. Planned start Feb 2026; status: not yet recruiting.
02
Conditions
pulmonary nodules (SPN)lung cancer
Beyond the preview
Go deeper on NCT07409129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07409129.